The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 39
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte BARRETT ROLLINS, and
CHARLES STILES
__________
Appeal No. 2001-0869
Application No. 08/453,347
__________
ON BRIEF
__________
Before WILLIAM F. SMITH, SCHEINER, and GRIMES, Administrative Patent
Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. § 134 from the examiner’s
final rejection of claims 1-16, all of the claims remaining. Claims 1-6 are
representative and read as follows:
1. A method of suppressing tumor formation in a mammal
comprising administering to said mammal tumor killing cells
which have been genetically engineered to express
JE/monocyte chemoattractant protein-1 when present in the
mammal.
2. A method of Claim 1 wherein the tumor killing cells are tumor
infiltrating lymphocytes.
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007